Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapy.
Stechele M, Link H, Hirner-Eppeneder H, Alunni-Fabbroni M, Wildgruber M, Salvermoser L, Corradini S, Schinner R, Ben Khaled N, Rössler D, Galun E, Goldberg SN, Ricke J, Kazmierczak PM.
Stechele M, et al. Among authors: hirner eppeneder h.
Radiat Oncol. 2023 Jul 28;18(1):125. doi: 10.1186/s13014-023-02316-2.
Radiat Oncol. 2023.
PMID: 37507808
Free PMC article.